[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584170":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":38,"collaborators":7,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":48,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Liem Binh Luong Nguyen, Degree medical doctor","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","0033 1 58 41 28 58","liem.luong@aphp.fr",{"name":18,"role":14,"phone":15,"phoneExt":7,"email":19},"Odile LAUNAY, PUPH","odile.launay@aphp.fr",[21],{"facility":22,"status":23,"city":24,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"CIC 1417Cochin-Pasteur","RECRUITING","Paris","75679","France","FR",{"type":29,"coordinates":30},"Point",[31,32],2.3488,48.85341,{"lat":32,"lon":31},[35,36],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"name":18,"role":14,"phone":37,"phoneExt":7,"email":19},"00 33 1 58 41 28 58",{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100584170","evaluation-of-long-term-immunogenicity-of-a-boost-dose-of-mva-bn-vaccine-100584170",false,"NCT06885853","Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine","M-BOOST-FR","Inclusion Criteria:\n\n* Men aged over 18 years\n* Have received two doses of MVA-BN vaccine as an initial schedule\n* Eligible for a booster dose of MVA-BN (according to the HAS recommendation)\n* Be eligible and wish to initiate PrEP-HIV treatment or be followed for PrEP-HIV treatment\n* Covered by social security (excluding AME)\n\nExclusion Criteria:\n\n* History of mpox (virologically confirmed)\n* Be under guardianship or curatorship\n* Be subject to a judicial protection measure\n* Have a contraindication to vaccination against mpox","ALL","18 Years",{"count":50,"type":51},90,"ESTIMATED","OBSERVATIONAL","This study is to evaluate the long-term immunogenicity of a boost dose of MVA-BN vaccine",[55],"Monkeypox",[55,57,58],"MVA-BN booster vaccine","HIV pre-exposure prophylaxis","2025-05-14",{"date":61,"type":62},"2025-05-15","ACTUAL",{"date":64,"type":62},"2025-05-07",{"date":66,"type":51},"2027-11",{"name":5,"class":6},1]